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Abstract
Background: Despite a lower incidence of bowel cancer overall, Indigenous Australians are more likely to be
diagnosed at an advanced stage when prognosis is poor. Bowel cancer screening is an effective means of
reducing incidence and mortality from bowel cancer through early identification and prompt treatment. In 2006,
Australia began rolling out a population-based National Bowel Cancer Screening Program (NBCSP) using the Faecal
Occult Blood Test. Initial evaluation of the program revealed substantial disparities in bowel cancer screening
uptake with Indigenous Australians significantly less likely to participate in screening than the non-Indigenous
population.
This paper critically reviews characteristics of the program which may contribute to the discrepancy in screening
uptake, and includes an analysis of organisational, structural, and socio-cultural barriers that play a part in the
poorer participation of Indigenous and other disadvantaged and minority groups.
Methods: A search was undertaken of peer-reviewed journal articles, government reports, and other grey literature
using electronic databases and citation snowballing. Articles were critically evaluated for relevance to themes that
addressed the research questions.
Results: The NBCSP is not reaching many Indigenous Australians in the target group, with factors contributing to
sub-optimal participation including how participants are selected, the way the screening kit is distributed, the
nature of the test and comprehensiveness of its contents, cultural perceptions of cancer and prevailing low levels
of knowledge and awareness of bowel cancer and the importance of screening.
Conclusions: Our findings suggest that the population-based approach to implementing bowel cancer screening
to the Australian population unintentionally excludes vulnerable minorities, particularly Indigenous and other
culturally and linguistically diverse groups. This potentially contributes to exacerbating the already widening
disparities in cancer outcomes that exist among Indigenous Australians. Modifications to the program are
recommended to facilitate access and participation by Indigenous and other minority populations. Further research
is also needed to understand the needs and social and cultural sensitivities of these groups around cancer
screening and inform alternative approaches to bowel cancer screening.
Background
Australia has one of the highest rates of bowel cancer in
the world [1]. It is currently the second most commonly
diagnosed cancer in men and women, and the third
leading cause of cancer-related deaths in the country
[2]. While mortality from bowel (also known as colorec-
tal) cancer in the general population has declined in
recent years, the situation among Aboriginal and Torres
Strait Islanders (hereafter Indigenous) is not so encoura-
ging, with some data showing that bowel cancer is
increasing as a significant cause of premature death
[3,4]. Similar patterns have been observed in Indigenous
populations across the world including Inuit and First
Nations in Canada and Maori in New Zealand (N.Z),
generally attributed to an increasingly westernised life-
style [5-7].
Cancer screening aims to identify unrecognized dis-
ease in individuals at average risk who are asympto-
matic. Only 40% of bowel cancers are detected in their
early stages primarily because very few if any symptoms
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thus making screening an invaluable tool for cancer pre-
vention [2]. Early diagnosis and intervention can sub-
stantially improve treatment outcomes and survival in
patients diagnosed with bowel cancer.
Commencing with Phase 1 in 2006, Australia imple-
mented a large, nation-wide organized screening program
for the prevention and early detection of bowel cancer.
Population screening programs require high uptake by
the target group in order to make an impact on health
and benefit the population being screened [8], however,
participation by Indigenous Australians in the program
has been poor [9,10]. By recognising and addressing bar-
riers to screening uptake, significant changes were made
to the national cervical cancer screening program to
accommodate for Indigenous women’s needs, and we
argue that a similar approach is necessary for the
National Bowel Cancer Screening Program (NBCSP) [11].
This review provides a descriptive and critical analysis
of Australia’s NBCSP in order to identify key character-
istics of the program that could inadvertently exclude
and impact on participation by Indigenous people and
other ethnic minorities. Specifically, it examines organi-
zational aspects and socio-cultural barriers facing Indi-
genous Australians in accessing and engaging in a
program which does not take into account their social
and cultural diversity, and healthcare access inequities.
While our focus is on characteristics of the program
that may discourage and hinder participation by Indi-
genous Australian, the issues highlighted are also rele-
vant to other ethnic minority and disadvantaged groups
and people living in remote locations. Such issues need
open discussion in order to catalyse policy and program
changes to ensure a more equitable and accessible pro-
gram for all Australians.
Methods and Results
Search strategy and approach
This review draws upon the existing literature to iden-
tify problematic areas in the Australian NBCSP that
need to be addressed to optimize the program for Indi-
genous people. The dearth of information available on
Indigenous populations in relation to bowel cancer
screening particularly in Australia, required that we
broaden our examination to studies with minority and
ethnic groups and also take lessons from breast and cer-
vical screening studies which have been more exten-
sively studied in Indigenous populations.
We undertook a search of the literature for material
relevant to the following research questions:
￿ What is the current state of bowel cancer and
bowel cancer screening among Indigenous
Australians?
￿ How is the NBCSP disseminated and what may be
influencing Indigenous participation?
￿ Are there any aspects of the program which appear
problematic and which could be modified to
improve participation?
Similar to the critical interpretive synthesis approach,
the process of literature searching was dynamic and
reflexive with themes emerging as the literature was
searched. This served to shape the content of the review
[12]. In contrast with systematic reviews, where inclu-
sion and exclusion criteria are defined at the outset, our
approach was more appropriate in the context of limited
availability of literature. Yet, our critique drew upon ele-
ments of a systematic review, including an initial metho-
dical and structured search of the literature using
electronic databases to synthesise and appraise the infor-
mation available.
Peer reviewed journal articles were selected following
a search of electronic databases including Proquest,
Science Direct, Google Scholar, PubMed, Medline,
Informit and ISI Web of Knowledge. Key search terms
used included a combination of the following: Indigen-
ous or Aboriginal with cancer screening, bowel cancer,
colorectal cancer, colon cancer with screening; ethnic or
racial minorities and disparities in colorectal or bowel
cancer screening. Other search terms included, Native
American and Alaska Native, Maori, First Nations, Inuit
and Metis, ethnicity or ethnic minorities with colorectal
or bowel cancer screening. Additional articles were
obtained through citation snowballing. The Australian
Indigenous Health InfoNet, the Australian Institute of
Health and Welfare, the Australian Bureau of Statistics,
Australian and State Cancer Council websites and pub-
lished and unpublished government reports also pro-
vided useful information and links.
Publications were considered for inclusion if they
addressed at least one of the above research questions
and contained information about colorectal cancer inci-
dence, mortality and survival or colorectal cancer
screening participation in Indigenous populations and
racial/ethnic minority groups. Articles examining knowl-
edge, attitudes, beliefs and barriers toward colorectal
cancer screening uptake and interventions to improve
screening uptake in these populations were also
included. Literature was not limited to Indigenous Aus-
tralians or Indigenous populations because of the dearth
of studies available. As literature on colorectal cancer
screening in Indigenous Australians was minimal, papers
looking at breast and cervical screening practices were
included to identify participation levels, barriers and
interventions for increasing uptake. Papers that did not
refer to an Indigenous, minority or disadvantaged group
were excluded.
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1.1 Bowel cancer in Indigenous Australians- epidemiology
and data quality
Although bowel cancer is rarely noted as a significant
health issues for Indigenous Australians, it is the third
most common cancer after lung and breast in women,
and lung and prostate in men, accounting for about 10%
and 9% of all cancers respectively [13]. However, the
lack of national data has meant that little information is
available surrounding the impact of bowel cancer on
Indigenous Australians. The Australian Institute of
Health and Welfare (AIHW) reports that incidence and
deaths from bowel cancer are much lower than the
non-Indigenous population [13], although the true mag-
nitude of bowel cancer is not clear due to problems
associated with under-ascertainment of Indigenous sta-
tus in cancer data collection registries. The Australian
Government recognizes three criteria as determining
Aboriginal and Torres Strait Islander status: - Indigen-
ous descent; self-identification as an Indigenous person
and acceptance of the individual as Indigenous by the
Indigenous community [14]. Administrative data collec-
tions generally focus on self-identification to classify an
individual as Indigenous, and while ascertainment of
Indigenous status is improving over time in Australia,
under ascertainment is an acknowledged problem with
gaps in the data that affect the accuracy of statistics
recorded [14]. Consequently, Indigenous cancers are
thought to be underestimated by up to 20% and mortal-
ity up to 35% [13,15,16].
The observed low incidence and mortality from bowel
c a n c e rm a yb ei n f l u e n c e db yan u m b e ro fo t h e rf a c t o r s ,
including the high rate of incomplete or inadequate
death certification and the large proportion of cancers
of undefined primary site in registered Indigenous can-
cer records [13,17]. Additionally, as cancer risk increases
with advancing age, the substantially lower life expec-
tancy of Indigenous Australians means they may die
from other chronic conditions prior to cancer diagnosis
[18]. Lower participation in cancer screening and the
possibility that Indigenous people with bowel cancer
may avoid seeking medical care for symptoms or acces-
sing treatment could also reduce ascertainment of dis-
ease [19-22].
Age-standardized incidence rates from 2002-2004 sug-
gest that the rate of bowel cancer in Indigenous Austra-
lians is about half that of the non-Indigenous
population (39.7 vs 76.4 per 100 000 in males and 36.6
vs 52.4 in females; rate ratios are 0.5 for males and 0.7
for females) [13]. Incidence data collected from cancer
registries (2002-2006) in three Australian states which
have the most reliable data collections gave a slightly
lower overall age standardized rate of 29.9 per 100 000
among Indigenous people compared to 64.7 per 100 000
in non-Indigenous [16]. However, these figures mask
higher rates that exist in younger Indigenous Austra-
lians. Age-specific rates show that incidence was similar
in non-Indigenous and Indigenous people up until age
50. Notably, men in the 40-49 year age group were
found to have higher rates of rectal cancer than non-
Indigenous men, attributed to greater consumption of
alcohol. Supporting the increased burden at a younger
age are findings from the Northern Territory (NT) indi-
cating that incidence rate ratios were higher in Indigen-
ous Australians under 64 years compared to those over
64 years (0.6 vs 0.2; 1991-2001) [3,4].
Colorectal cancer (CRC) mortality estimates vary in
different jurisdictions. In a NT study (1987-95), age
standardised mortality rates in Indigenous people were
about half that of non-Indigenous people [22], while in
rural and remote Queensland and in New South Wales
mortality rates were not significantly different between
Indigenous and non-Indigenous people [15,23]. A more
recent NT analysis showed mortality rates were similar
in Indigenous compared to non-Indigenous people
under 65 years, but substantially lower in older ages,
suggesting an interaction between age and Indigenous
status [24]. This was further supported by recent results
from four Australian states, where despite somewhat
lower age standardised death rates in Indigenous people
(17.9 per 100 000 compared to 19.8 in the non-Indigen-
ous population) age-specific mortality rates were actually
higher in Indigenous people under 60 years compared to
the non-Indigenous population [25].
Indigenous Australians generally have higher mortality
following a cancer diagnosis compared to non-Indigen-
ous Australians, especially for those cancers which are
amenable to early diagnosis and treatment [22,26]. Later
staging at diagnosis means patients present with more
advanced disease and experience poorer treatment out-
comes; Indigenous people also appear less likely to
undergo and comply with treatment [19,21]. This has
also been shown to be true for CRC [21]. Thus, once
diagnosed, Indigenous people are more likely to die
from CRC compared to their non-Indigenous counter-
parts as reflected in the poorer five year survival rate.
Condon et al. [21] found that nearly 90% of Indigenous
people with CRC in the NT presented with advanced
disease at diagnosis as opposed to 68% of the non-Indi-
genous group, and that five year survival was only 31%
compared to 55% in the non-Indigenous group [4]. This
pattern is consistent with CRC mortality and survival
observed in Maori, Native Americans, Native Hawaiians,
First Nations and Inuit [6,27-31].
Reasons behind late presentation and delayed diagno-
sis have been explored in studies examining breast and
cervical cancer in Indigenous people and include a low
awareness of symptoms, delay in seeking medical advice,
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tic and specialist services, and a disinclination to seek
advice for symptoms because of certain beliefs regarding
cancer and the chance of successful treatment [4,32].
Late presentation and poor survival is also influenced by
communication and cultural barriers which may impact
the effectiveness and choice of treatment, as well as the
decision to engage in preventive and diagnostic activities
including cancer screening [19,20,33]. The presence of
other chronic diseases or environmental conditions also
limits provision of treatment due to the risk of compli-
cations [4,21,26,34].
National cancer screening programs can partly address
the survival discrepancy in Indigenous Australians by
facilitating early diagnosis. If implemented in a culturally
sensitive manner, cancer screening can aid in reducing
mortality from the disease [26]. This has been demon-
strated in the NT and WA where cervical cancer mor-
tality declined substantially following the provision of a
culturally appropriate holistic cancer screening services
[35-37]. However, Australia’s national bowel cancer
screening program in its current form has not taken
such an approach, reflected in the very low uptake by
the Indigenous population.
1.2 Bowel cancer screening and Australia’s National Bowel
Cancer Screening Program
Bowel cancer screening is an effective means of reducing
the mortality and burden of CRC in the community
through the early detection of abnormal changes in the
bowel [38,39]. It is an ideal malignancy to target for
population screening and fits the World Health Organi-
sation’s criteria for suitability for population based
screening [38]. Importantly, it has an identifiable early
precursor lesion, usually in the form of an adenomatous
polyp which in most cases is asymptomatic; it has a
long latency period (for a polyp to become cancerous),
thus providing an opportunity for early diagnosis; and
there is a high cure rate if found with available effective
treatment. Five year survival rates can be almost 90% if
a tumour is detected in the earliest stages (Stage A)
while still asymptomatic and localized. Once cancer has
proceeded through the bowel wall, to the lymph nodes
and beyond, five year survival is reduced to only 7%
[38,40]. In South Australia (SA), a monitoring system
showed that only 15% of bowel cancers were detected at
Stage A indicating that substantial potential improve-
ments in survival could be achieved with earlier diagno-
sis [41].
Australia is one of a few countries implementing a
formal, government funded, population-based CRC
screening program - others include the UK, Canada,
France, Italy and Finland [42-44]. Following a bowel
cancer screening pilot program in 2002-2004
which examined the feasibility, acceptability and
cost-effectiveness of the program in the Australian
community, the first phase of the National program
w a sr o l l e do u ti n2 0 0 6a n dw a so f f e r e dt op e o p l et u r n -
ing 55 and 65 years of age. The second phase began in
July 2008 and expanded eligibility to all men and
women turning 50, 55 or 65. The program targets only
specific ages due to limited funding and to ensure that
health services can cope with the increased service
demands [9]. The target population age range was cho-
sen based on the National Health and Medical
Research Council guidelines which indicated the risk
of developing bowel cancer increases significantly over
the age of 50 years, with over 90% of those diagnosed
with CRC in Australia aged over 50 [25].
Funding for the NBCSP has been secured only until
2011, allowing for once-off testing of the population -
despite the fact that the mortality benefit associated
with screening depends on regular participation [45].
The program is freely available to people aged 50, 55
and 65 years only and no plans have been announced
for second yearly screening. If fully implemented to a
broader age range and with ongoing screening rounds,
the program could potentially save up to 2,000 lives per
year in Australia [46]. Furthermore, sequential screening
can also provide an estimation of incidence (new dis-
ease) since last screen, as opposed to the initial screen-
ing round which cannot differentiate between new and
old cases.
The Bowel Cancer Screening Implementation Com-
mittee chose the faecal occult blood test (FOBT), a sim-
ple non-invasive test that detects small amounts of
blood in the bowel motion, as the test of choice for
population screening in Australia. The presence of
blood in faeces is a sign that abnormalities such as a
precancerous lesion or cancer may be present in the
bowel. Landmark trials have shown that regular popula-
tion screening using FOBT can reduce the risk of death
from CRC by up to 33% in those who (regularly) partici-
pate [39,45,47]. FOBT is the only screening test for CRC
where evidence from RCTs demonstrated a reduction in
mortality [48], although the trials used the guaiac FOBT
(gFOBT) as opposed to immunochemical FOBTs
(iFOBT), the test used in Australia. One recently com-
pleted RCT using the iFOBT demonstrated increased
detection and compliance, although long-term mortality
benefits have yet to be demonstrated [49].
The screening pathway is shown in Figure 1. Screen-
ing test kits are mailed to individuals following identifi-
cation of eligible program participants from enrolment
in the national healthcare insurance scheme (Medicare).
Kits are completed at home by taking samples of two
consecutive bowel motions and mailed back to a pathol-
ogy laboratory for testing without cost to the patient.
Results are sent back to participants and their
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Page 5 of 21nominated GP (if one has been nominated). For positive
tests, a letter advises participants to visit their GP to dis-
cuss a follow-up procedure, namely colonoscopy. A
bowel cancer screening register has been established
within Medicare to assist in follow-up of those with
positive tests not undergoing colonoscopies, rescreening
of participants, and to aid data collection, monitoring
and evaluation [9]. The data obtained are collected via
forms filled in by the individual, their GP, colonoscopist
and others involved. As completion of the forms is not
compulsory, a large amount of information is incom-
plete or missing [25].
The sensitivity and specificity of FOBT varies by test
type and manufacturer. Sensitivity is in the order of 60-
85% for iFOBTs when used regularly within a program,
although with once-off testing this drops to 30-50%
[48]. The iFOBT (MagStream 1000/Hem SP) currently
used in the Australian program has a sensitivity of 66%
for cancer and 20% for polyps over 1 cm [50-52].
Hence, many false positives occur, resulting in high
numbers of follow-up colonoscopies. Of those who have
a positive FOBT, about 5-10% will have CRC, and 20-
35% will have an adenoma identified [41]. Test out-
comes and the ability of the test to identify CRC are not
usually fully understood or made apparent to the public,
yet are important when weighing up the risks and bene-
fits associated with participation in the program [53].
In 2009, nearly half a million testing kits were recalled
and the program was temporarily suspended for six
months after an unusual decline in the number of posi-
tive test results, assumed to be due to faulty kits. Test-
ing resumed in November 2009 with a new kit that was
initially distributed to re-screen those who received the
faulty kits [54]. However, the new kit is recommended
for use only up to 30 degrees Celsius creating potential
problems for many regions, particularly in the north of
Australia where a large proportion of Indigenous people
reside. The new screening kit will not be sent to these
regions initially, creating even further inequities in
access. Much greater thought and effort needs to be put
into the problem of differential access to the program.
1.3 Indigenous participation and test profile - results of
National Bowel Cancer Screening Program monitoring
reports, 2006-2008
Adequate levels of participation are essential for the
success of a screening program in reducing mortality
from CRC and for population benefit equating to that
attained in randomized controlled trials [8]. It is also
an important contributor to the cost-effectiveness of
the program in terms of number of lives saved and
costs saved by averting a cancer diagnosis [8,55]. Mon-
itoring reports completed in 2007, 2008 and 2009
details performance of the program from 2006-2008
[10,25,56].
Overall participation in the Australian NBCSP was
37.6% by the end of 2008 however, participation was
lower than that observed during the pilot (45.4%). The
average positivity rate was 6.6%, significantly higher
among men than women which is reflected in higher
incidence rates [25]. Table 1 details variation in partici-
pation, positivity rate and proportion of correctly com-
pleted tests according to demographic factors.
Analyses up until mid-2008 showed Indigenous parti-
cipation was 17% - less than half the non-Indigenous
rate [10]. In the 2009 monitoring report which docu-
mented results from 2008 only, Indigenous people were
2.2 times less likely than non-Indigenous to participate
in the screening program [25]. However, Indigenous
identification of participants in the program was
through self-report and was completed by only 63% of
participants. Another important finding from the 2008
report was that Indigenous people were significantly less
likely to complete the FOBT correctly, with Indigenous
females aged over 65 years having the lowest rate of
correctly completed tests [10]. Indigenous people also
had higher FOBT positivity rates although this was not
significant due to the small sample size [25]. The pro-
portion of correctly completed tests was also signifi-
cantly lower for people who nominated a language other
than English as their preferred language [10]. Significant
differences were also observed according to geographic
location, with inner regional areas having the highest
rates of participation while those in remote and very
remote areas (where 26% of Indigenous Australians
reside) were significantly less likely to participate. Parti-
cipation also fell with lower SES [10], and those in the
most disadvantaged lowest quintile of the population
were significantly less likely to follow up a positive result
with their GP. Indigenous Australians are disproportio-
nately represented in this quintile.
Substantial numbers of unreturned health provider
forms make it impossible to determine how many Indi-
genous (or other) people with positive FOBTs went on
to complete a colonoscopy. For the entire program, only
42% of participants with a positive FOBT had a colono-
scopy recorded. The remaining participants either did
not have a colonoscopy or the colonoscopy report was
not returned [25]. Lack of quality surveillance informa-
tion compromises the assessment of actual population
benefits and the impact on the incidence and mortality
from CRC, particularly on population subgroups.
Despite this, a recent analysis by Ananda et al [57]
assessing the initial impact of the NBCSP from mid
2006 to mid-2008, reported its success in identifying
CRC at an earlier stage. This study utilised linked data
from hospitals across Australia to gather information on
CRC cases reported by surgeons and found that 40% of
cancers identified through the NBCSP (N = 40) were at
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spoken
Participation
rate
Gender Males Females Total Females 1.2 times more likely to participate than males
36.2 *(2008) 43.3* (2008) 39.7
36.0 (2009) 42.6 (2009) 39.3
Indigenous
Status#
Non-
Indigenous
Indigenous Total Indigenous people are 2.3 times less likely to participate Than
non-Indigenous people
38.6 (2008)* 17*(2008) 38.3
37.0* 17.0*
45.4 (Pilot)
SES Lowest SES Highest
SES
Participation significantly lower in the most disadvantaged
quintile compared to any other quintile
37.5*(2008) 41* (2008)
Geographic
Location
Very Remote Remote Outer
Regional
Inner
Regional
Cities Total
Proportion of those who participate was significantly lower in
remote and very remote compared to the national level.
Participation was significantly higher in inner regional compared
to other areas.
25.6*(2008) 35.5 40.9 43.7 38.4 39.7*
25.0(2009) 39.1 40.1
Spoken
language
English as
preferred
language
Other
language
preferred
Those whose preferred correspondence language was English
were 1.6 times (2008) and 2.9 times (2009) more likely to
participate
42.2* (2008) 27.0* (2008)
41.1* (2009) 14.0* (2009)
FOBT Positivity rate
Gender Males Females Total
8.9* 6.4* 7.5
(2008)
7.7 5.7 6.6
(2009)
Indigenous
Status#
Non-
Indigenous
Indigenous Not statistically significant difference due to small numbers
7.5 (2008) 8.6 (2008)
6.6 (2009) 8.1 (2009)
Geographic
location
Very Remote Remote Outer
Regional
Inner
Regional
Cities Total
8.7*(2008) 8.7*(2008) 8.6* 7.9* 7.2* 7.5
8.4 (2009) 7.8 (2009) 7.3
(2009)
6.4
(2009)
SES Low SES Highest
SES
7.8 (2009) 5.5 (2009)
Proportion of correctly completed tests
Indigenous
status#
Non-
Indigenous
Indigenous
Significantly lower in Indigenous compared to non-Indigenous
participants. Indigenous females aged over 65 have lowest
correctly completed tests
96.3 * 93.9 *
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among individuals who presented with symptoms to
their doctor [57].
Critical Review and Interpretation
1.1 Factors contributing to poor uptake of bowel cancer
screening in Indigenous populations
An individual’s decision to engage in CRC screening is
complex and influenced by socio-cultural, historical, sys-
tem and organizational factors, and individual beha-
vioural factors - all of which impact on screening uptake
at a population level [8,58]. Unfortunately, the design of
screening programs often does not reflect the diversity of
social and cultural values of a nation’s population, creat-
ing significant barriers to participation in CRC screening.
Bowel cancer screening using the FOBT differs quite
considerably from other screening programs in its com-
plexity, and is unique in many ways which makes it a
difficult program to promote. A self-administered test
requires that one complete it at home and return it,
hence relying on individuals to take initiative and follow
instructions. Moreover, people may find it an unpleasant
test to complete, and the first faecal sample must be
stored appropriately until the other is taken. CRC
screening targets both males and females, which not
only increases the size of the target population, but
men’sl a c ko fp r e v i o u si n v o l v e m e n ti ns c r e e n i n gp r o -
grams poses additional challenges for recruitment.
There is also some confusion surrounding the age
groups for screening with inadequate understanding by
and explanation to participants as to why only certain
people are chosen. As with most screening tests the
FOBT is not diagnostic and only identifies those at high
risk, so further investigation is necessary for a definitive
diagnosis to be made, making the process longer and
more stressful for the client. Thus, participation must be
addressed along the entire screening pathway - at the
screening stage, if further investigation with colonoscopy
is required, then again when treatment is required.
Where ongoing screening is incorporated into the pro-
gram, difficulties arise getting people to return for sub-
sequent two-yearly screens.
Table 1: Participation in the NBCSP according to Indigenous status, gender, SES, geographic location and language
spoken (Continued)
Preferrred
language
English Other Total Significantly lower number of correctly completed tests among
those whose preferred language is not English
96.7* 91.7 * 96.2
Disability
status/activity
limitation#
Severe or
profound
None Total Significantly lower number of correctly completed tests in those
with activity limitation
90.6* 96.5* 96.2
Geographic
location
Very Remote Remote Outer
regional
Inner
regional
Major
cities
Total
96.0 97.4* 96.8* 96.9* 95.8* 96.2
Primary Practitioner visits after a positive test
Indigenous
status#
Indigenous Non-
Indigenous
Total No significant difference
46.4 43.7 43.2
Preferred
language
English Other
language
Those with a preferred language other than English were
significantly less likely to visit a GP after a positive test result.
43.6* 40.0*
SES Lowest SES Highest
SES
Those in the most disadvantaged quintile were significantly
more likely to see a GP following a positive test result
43.9* 40.4*
Percentages are the number of people participating as a proportion of the total number of the eligible population who were sent invitation to screen
2008 - 2008 Monitoring report reports performance of NBCSP from 30 June 2006-7 August 2008. Included 55 and 65 year olds
2009 - 2009 Monitoring report reports performance of NBCSP from January 2008- 31 December 2008. Included 50, 55 and 65 year olds
*significant difference exists
#Disability status and Indigenous status were self reported measures
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Indigenous populations
Country Organised Screening Program CRC Incidence CRC Mortality Screening
recommendations/
characteristics
Participation by
Indigenous groups
(per 100 000) (per 100 000)
Indigenous vs non-
Indigenous
population
Indigenous vs non-
Indigenous
population
Australia Yes 36.6 vs 52.4 [13] for
females**
17.9 vs 19.8^^ [115] Free once-off iFOBT
For those aged 50,
55 & 65 yrs
17% compared to 39% in
non-Indigenous [115,10]
Kit posted to all in
these age groups
39.9 vs 76.4 [13] for
males**
Currently only a
once-off test
New
Zealand
No 15.5 vs 24.1*[116] 8.8 vs 9.8* [116] No program in
place yet
No data available
Once diagnosed with
CRC, Maori are two
thirds more likely to
die
Relative risk of mortality
in Maori is 1.24 after
adjusting for age, sex
and stage [6]
Opportunistic
screening only
Mortality: Incidence
ratio:
57%
Maori vs
41% in
non-
Maori
Canada Yes 37.2 vs 34.8 for
females
c
16.1 vs 18.4 [118]
b FOBT (guaiac) every
2 years 30% adherence in general
population but no specific
data on Indigenous
participation [94]
(in certain provinces only ie. Ontario
and Alberta)
55.1 vs 67 for males
c
[117]
For those aged
50-74 yrs.
Kit obtained free
from health care
provider.
Information sheet
available in Inuit
language.
USA No
33.9 (AI/AN ranged
from 17.1-106.2) vs
53.2 (non Hispanic
whites) [119,120]^
17.9 (AI/AN) vs 21.0
(USA all races)
a [121]
Recommendation
by professional
organisation for
either;
Any CRC screening in last
2 years:
(Recommendations in place but no
organised or national program.
Primarily opportunistic and some
state programmes exist)
Mortality rate ratio: 1.15
vs 0.89 (10)
a
Annual FOBT or 38.1% AI/AN vs 58.5%
non-Hispanic white [122]
5 yearly flexible
sigmoidoscopy or
FOBT: 5.8% (AI/AN) vs
12.6% (white) [120]
combination of the
above two, or
Sigmoidoscopy or
colonoscopy:
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Page 9 of 21Lower screening uptake by certain racial/ethnic and
minority groups has consistently been documented in
countries implementing CRC screening programs
[59-62]. Lower participation also occurs among the less
educated, lower income groups, and those from non-
English speaking backgrounds [10,58,63,64]. Studies
controlling for SES and other factors such as distance
from services and education show that race and ethni-
city are independent predictors of CRC screening uptake
[28,65].
Research reveals that beliefs and attitudes of ethnic
and minority groups in regard to cancer and cancer
screening can differ quite significantly from the majority
mainstream population which may have important
implications for participation in cancer prevention
efforts and treatment [17]. A number of studies in the
USA have identified differing views and beliefs that
could act as motivators or barriers to CRC screening
[66-68]. A study of American Indian and Alaska Natives
(AI/AN) found that having a family history of cancer,
higher education and income, presence of other chronic
conditions, speaking English at home, urban residence,
and older age were predictors of CRC screening partici-
pation [69]. Researchers examining other ethnic groups
have identified that being physically active, having a
greater perceived susceptibility to CRC, a doctor’s
recommendation and participation in other screening
programs as important predictors of screening adher-
ence [70], while lack of knowledge, lower perceived risk
and perceived self-efficacy, inaccurate beliefs, language
and communication barriers, fatalism, the belief that
screening is not necessary without symptoms, lower
levels of utilisation of health services, the failure of a
doctor to recommend screening and cost are significant
barriers to screening [66,67,71,72].
Many other developed countries with Indigenous
populations are in the beginning stages of CRC screen-
ing and while uptake by Indigenous populations has not
been extensively studied, early data also indicate lower
participation. Table 2 shows differences in CRC screen-
ing participation by Indigenous compared to the non-
Indigenous population in four industrialised countries,
outlining variations in screening recommendations, the
type of screening test and how the screening is targeting
individuals.
Cancer screening programs have had variable success
among Indigenous people in Australia. The low partici-
pation rates observed for the NBCSP reflect similarly
poor engagement of Indigenous women in cervical and
breast screening programs, with participation in the
order of 30-35% compared to 55-60% in non-Indigenous
women [3,37,73]. Indigenous communities face several
barriers to accessing cancer-related health services,
including early detection programs [74,75]. Evidence
from studies assessing breast and cervical screening
uptake by Indigenous women in Australia suggest that
participation is influenced by multiple structural, socio-
cultural and behavioural factors similar to those
described above (see Table 3), including poor knowledge
and awareness of cancer and the benefits of screening
prevention services, culturally insensitive services, shame
and fear regarding cancer, lack of Indigenous or female
service providers, distrust of the mainstream providers,
low literacy, poor coordination of services as well as dis-
tance and access barriers [3,17,76-78]. The absence of
sufficient Indigenous-specific, culturally relevant, educa-
tional resources has also been identified as an important
factor impeding cancer prevention efforts [74,79-81]. To
date, no published studies in Australia explore barriers
specifically towards bowel cancer screening in
Table 2: Differences between CRC and CRC screening programs in selected industrialised countries with disadvan-
taged Indigenous populations (Continued)
10 yearly
colonoscopy
31.7 (AI/AN) vs 45.8
(white) [120]
For everyone over
50 yrs [48]
Endoscopy or FOBT: 34.4
vs 49.5 [120]
All figures are per 100 000 and are age-standardised
Abbreviations
AI/AN- American Indian/Alaska Native
iFOBT- immunochemical FOBT
gFOBT- guiac FOBT
^ 1999-2004 Included only those that attended Indian Health Services and limited to Contract Health Service Delivery Area Counties. Standardised to 2000 USA
population
^^ Age standardized mortality rate from 2002-2006 Queensland, Western Australia, South Australia and Northern Territory combined
** Age standardized incidence rate 2000-2004. Data for NSW, Vic., Qld, WA, SA and NT combined
* 1996-2001 Standardised to Maori population
a Rate adjusted to the 2000 USA standard population
b Age standardized to the 1991 Canadian Population. Mortality rates are from 2000 for First Nations and 2001 for Canada. First Nation rates are for on reserve
but include the off reserve population for British Columbia and Alberta
cAge standardized to the 1991 Canadian population. Rates are from 1997-2001
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Page 10 of 21Indigenous people other than an evaluation conducted
following the pilot program in 2004 which interviewed
only 15 people - 8 participants and 7 non-participants
[82].
However, a study of Italian migrants in Australia
found similar issues and beliefs to Indigenous Austra-
lians - fatalism, English proficiency, fear of cancer and
finding out they have cancer, inadequate knowledge and
misconceptions of causes of bowel cancer [83]. Weber
[84] also explored uptake of cancer screening in Austra-
lian migrants and found a significantly lower participa-
tion rate in bowel cancer screening among Asian men,
although as the authors noted, the NBCSP had not
begun in Australia at the time of the survey [84]. This
highlights the importance of identifying the needs and
preferences of minority groups so as to appropriately
target them for bowel cancer screening. To successfully
target messages, educational resources and interventions
for increasing uptake requires understanding of the cur-
rent knowledge, attitudes and beliefs of the community
of interest.
Potentially, screening could exacerbate inequalities in
health as a result of less participation by those of lower
SES or ethnic minority groups, including Indigenous
populations [8]. A recently completed study in S.A has
shown disparities in participation in the NBCSP accord-
ing to SES, gender and age [85]. Although many coun-
tries are examining ways of increasing participation by
disadvantaged groups, only N.Z has taken a serious
interest in avoiding increasing health inequalities before
implementing any sort of CRC screening program that
may negatively impact on the health of the Maori popu-
lation [86]. A CRC screening advisory group in N.Z
recommended that any screening program if implemen-
ted must: adopt a holistic approach to health and well-
being; establish partnerships with relevant Maori health
organisations; incorporate Maori language in informa-
tion and health promotion materials; and ensure partici-
pation of Maori in the planning and dissemination of
the program [87]. Such an inclusive approach with con-
sultation and involvement of the community is likely to
have a positive impact on participation and should be
explored further in Australia.
2.2 Findings from the evaluation of the bowel cancer
screening pilot program
A qualitative evaluation undertaken in 2005 of opinions,
attitudes and behaviours influencing participation or
non-participation in the pilot bowel cancer screening
program is the only available review which provides
some insight into Indigenous people’sv i e wo ft h eb o w e l
cancer screening program, its associated screening kit,
and reasons behind their decision to participate or not
[82]. However, only a very small number of Indigenous
people were involved (8 participants and 7 non-partici-
pants) and the target population of Indigenous people
was not considered representative, so the findings need
to be interpreted with caution.
The main issues that emerged were that lack of aware-
ness and knowledge of bowel cancer and related screen-
ing options as key barriers to participation. There was a
lack of understanding of bowel cancer and the benefits
of screening and early detection, with many unable to
distinguish bowel cancer from other cancers. Not having
Table 3 Barriers to cancer screening uptake as well as
follow-up and treatment in Indigenous populations
Socio-cultural and behavioural
barriers
Structural barriers
Individual barriers Access barriers
Poor knowledge and awareness
of cancer and screening services
Poor coordination of services, from
screening to follow-up and
treatment
Low levels of health literacy Lack of transportation
Language/literacy barriers Distance barriers/rural residence
Low perceived risk Frequent moving, changing address
Negative attitude Child care commitments (family
responsibilities)
Worry or fear of cancer Inflexible clinic schedules
Fatalism regarding cancer Lack of Indigenous staff
Low priority of screening Difficulties negotiating/
communicating with providers and
organizations due to language/
literacy or cultural differences
Perceived self efficacy
Lack of appropriate health
information
Presence of co-morbidities Lack of health promotion material
in Indigenous languages
History of racism and distrust in
medical institutions
Discomfort with mainstream
services/alienating hospital
environment
Absence of holistic, culturally
appropriate cancer services
Economic
Cost of seeing a GP including
transport
Unsure of potential costs of follow-
up and treatment
Costs for travel and
accommodation to hospital
Provider-related
Lack of understanding of cultural
needs
Poor identification of Indigenous
status
Lack of appropriate resources
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Page 11 of 21any symptoms and no family history of cancer were rea-
sons given for non-participation. In addition, there were
doubts about the efficacy of the test and some had con-
cerns about physically collecting the stool samples.
Rejection of the kit was often the result of anxiety and
confusion. The analysis showed those who completed
the kit required much encouragement and support from
h e a l t hw o r k e r sa n dG P sa st h e yb e l i e v e dt h a tt h e yd i d
not have the ability to correctly complete the test. Indi-
genous participants did not discuss the test with family
members nor did they actively seek assistance from
health professionals [82]. Indigenous people that partici-
pated were perceived to be more proactive, in control of
their health, and more literate. Participation was influ-
enced by personal experiences such as knowing some-
one with CRC, degree of community engagement and
access to information in a known language. Participants
in the pilot tended to have a better understanding of
why they were receiving the kit and the benefits of the
screening as they were more likely to have seen promo-
tions and media campaigns prior to receiving the kit
and so had an idea of what to expect and were not sur-
prised when they received it. This was an important
trigger for participation, as was contact and encourage-
ment from community health workers, the fact the test
was free, and a sense of privilege felt for being chosen
for participation. However, this latter factor also insti-
gated fear and anxiety in some people who felt that they
were at risk because they were targeted individually [82].
Additional barriers identified were similar to other
screening programs and included a fear of cancer and
the belief that cancer essentially means death. This find-
ing is consistent with research conducted into the per-
ceptions of cancer among Indigenous people [88]. There
is often a social stigma attached to cancer among Indi-
genous people [17] which may prevent people from uti-
lizing screening.
Bowel cancer screening has not had a strong advertis-
ing campaign to increase public education and aware-
ness, so that many people receive the test without being
aware of its purpose. Poor knowledge and understanding
of the program was highlighted as a major barrier to
participation in the pilot [82]. A study [89] assessing tel-
evision coverage of CRC concluded that the disease is
under-reported in the media relative to other cancers,
despite incidence and mortality rates being high. The
absence of celebrities speaking publicly of their CRC
experience was also noted, with publicity of affected
celebrities highly effective in influencing the public’s
perception and increasing uptake of screening [90]. The
2005 evaluation report echoed this need for more exten-
sive media coverage as a means to target hard-to-reach
populations [82]. Unfortunately, the program has
attracted some negative publicity since the incident with
faulty kits which has not helped the case for promoting
CRC screening.
2.3 How does the NBCSP exclude Aboriginal and Torres
Strait Islanders?
Several features in the way the NBCSP operates, includ-
ing downstream activities of follow-up and treatment,
make access for Indigenous people particularly challen-
ging. Many of these issues were highlighted in the 2005
evaluation report [91], yet to date no changes have been
made to the program. Outlined below and summarised
in Table 4 are specific elements of the program related
to the way it is organised and disseminated that could
contribute to unintentionally discouraging participation
by Indigenous Australians. Particular socio-cultural bar-
riers are also explored in relation to how they impact on
program participation.
i) Medicare enrolment requirement Enrolment with
Australia’s universal health insurance program, Medi-
care, determines who receives a screening kit, as this is
the sampling frame from which participants are selected,
based on their age [10]. Those who are not enrolled in
Medicare are likely to be individuals from poorer socio-
economic backgrounds, with lower English proficiency
and living in remote locations, so that the program
unintentionally excludes those from more disadvantaged
backgrounds, exacerbating the already widening dispari-
ties in health that exist. Indigenous people are less likely
to be enrolled with Medicare than non-Indigenous peo-
ple, with estimates from 1997 indicating enrolment rates
in the range of 65-80% for Indigenous Australians [92].
It is believed that enrolments have improved over the
past decade although recent estimates are not available.
Moreover, if addresses recorded by Medicare are not
updated - as may be the cases for many transient and
mobile Indigenous people - it is likely many people will
miss out on receiving a kit.
ii) Postal route of FOBT screening kit distribution
Delivery of the FOBT screening kit by post significantly
impedes participation, for those who do not have a fixed
address (or post box). This particularly affects mobile/
Table 4 Organisational and structural characteristics of
the NBCSP that may exclude participation by Indigenous
and disadvantaged populations
1. Medicare enrolment requirement
2. Postal route of FOBT screening kit distribution
3. Role of the General Practitioner
4. Target age group
5. Health information systems around recording Indigenous status
6. Other logistical issues- privacy, storage and test viability
7. Literacy requirement
8. Nature of the screening test
9. Barriers to compliance with follow-up and treatment
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Page 12 of 21transient populations and those living in remote areas or
who are homeless, situations more commonly experi-
enced by Indigenous than non-Indigenous Australians.
The NBCSP pilot evaluation identified this limitation to
participation and receipt of test results [9]. Arguably,
options are needed that enable those without fixed
address to receive a kit by alternative means, thereby
giving them similar access. Pilot activities are taking
place in some states in Australia exploring alternative
mechanisms of delivering kits to Indigenous people [93].
These include distributing kits from Aboriginal Medical
Services, opportunistic distribution of kits, and the utili-
sation of Aboriginal Health Workers to deliver kits and
follow up individuals with kits to encourage them to
complete the tests. These innovations are being
evaluated.
Despite greater flexibility in distribution being needed,
there is no national initiative to improve access for Indi-
genous people to the NBCSP through alternative target-
ing strategies. A mechanism is needed whereby those
who are interested in receiving a kit are able to obtain
one from their health centre, as occurs in Canada where
all people over the age of 50 are able to obtain a free
FOBT kit from their health care provider [94]. In Aus-
tralia, the possibility exists of broadly promoting cancer
screening through mobile vans visiting Indigenous com-
munities every two years, as is done for breast and cer-
vical screening. This may require addressing logistical
difficulties, including the need for the van to stay extra
days to give enough time for participants to provide two
samples.
iii) Role of the General Practitioner In Australia’s pro-
gram, general practitioners (GP) have a pivotal role to
play. They receive FOBT results of patients who nomi-
nate them as their GP, manage patients with a positive
test and organise referral for colonoscopy. GPs are also
responsible for notifying the central registry of patient
outcomes and any referrals for colonoscopies [10,95].
GPs have an important role in encouraging test com-
pletion [96], however, their pivotal position in the pro-
gram poses several problems which may limit access to
the program as well as to follow-up tests. Indigenous
people in general have lower levels of utilization and
access to GPs, especially regular GPs. This is particularly
true in rural and remote regions [91]. In the case where
an individual has received the kit and completed the
test but has not nominated a GP on the form, it is up
to the patient to initiate follow-up of their test results
with a doctor or nurse. A problem arises when an indi-
vidual has difficulty reading and understanding the letter
notifying a positive result and then acting upon it
appropriately. This is also a barrier for others like those
of CALD background, the elderly and those with disabil-
ities. Additionally, many Indigenous people have poorer
continuity of care, given the high doctor turnover in
many rural areas and in Aboriginal Medical Services
(AMSs). This has led to a large reliance on overseas
trained doctors [97] who are often referred to by their
first name, thus posing difficulties when identifying a
participant’s nominated GP. Alternative approaches the
program could employ include shifting some responsi-
bility from the doctors to the nurses and health workers
within clinics and hospitals. The bowel cancer screening
test could also be integrated into health services so
when a person of the target age presents with another
problem, a screening test is administered by a health
worker. At present there are no supplies of screening
kits available to AMSs or hospitals. Alternative
approaches could also be considered, such as in the UK
where screening hubs have been established and are
responsible for call and recall of the screening popula-
tion, issuing and analysing kits, arranging colonoscopies
and notifying GPs of patient outcomes [98].
iv) Target age group Despite overall incidence and
mortality rates being higher in non-Indigenous people,
Indigenous Australians die from CRC at a younger age,
before the targeted screening age [10]. For example, in
the 45-49 age group mortality rates in Indigenous Aus-
tralians was 11.3 per 100 000 compared with 7.8 for
non-Indigenous people. In the 50-54 year age group the
difference is even more marked with a rate of 24.1 for
Indigenous people while in non-Indigenous it is 7.8 [10].
Considering the time taken for a polyp to develop into
cancer may be over 10 years [38], it is crucial that Indi-
genous Australians are targeted for screening at a
younger age than the recommended 50 years. Reasons
for an earlier age of onset of CRC are not clear and
need to be identified, but may relate to exposure to
higher levels of risk factors at younger ages. In 2005/
2006 it was announced that Indigenous people could
participate in the NBCSP from the age of 45 [41], but it
is not clear whether FOBT kits are in fact being sent
out to Indigenous people at this earlier age. Given that
this would require Indigenous status to be reliably iden-
tified on Medicare enrolment records, a large proportion
of at-risk Indigenous people are likely to be missing out
on getting screened earlier.
v) Health information systems around recording Indi-
genous status For a participant to be identified as Indi-
genous in the NBCSP, they as well as their GP and
colonoscopist must all record Indigenous status on the
appropriate forms including reports that are sent to the
central registry. Information on Indigenous status
recorded within Medicare is currently voluntary, and a
large proportion of Indigenous people are not identified.
The lack of recording of Indigenous participation in
other screening programs has been noted to affect the
ability to determine to what extent screening is making
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Page 13 of 21an impact on cancer incidence and mortality [26]. Not
knowing how many Indigenous people are completing
the test and being followed up, impedes assessing how
well the screening program is targeting Indigenous peo-
ple, and hence the development and modification of the
program. Thus, adequate identification is crucial for
improving the delivery of screening services to the Indi-
genous population. The inadequate information systems
are reflected in the high loss to follow-up (45%)
observed in the NBCSP, both concerning and ethically
unacceptable as many people with a positive test could
miss out on colonoscopy and potentially lifesaving treat-
ment [25]. Although not a direct barrier, recording of
Indigenous status is important in evaluating participa-
tion, and targeting younger Indigenous people for a
screening kit.
vi) Other logistical issues- privacy, storage and test
viability Other logistical barriers relate to an indivi-
dual’s access to privacy needed to do the test and an
appropriate place to store samples until a second sample
is taken. The way the test is designed at present assumes
access to conventional housing with a private toilet.
Although the test does not need to be kept refrigerated
it is recommended that the sample is kept in a dark and
cool place. Many Indigenous people live in substandard
housing, sadly, many without functioning facilities. Sev-
eral families often live within one house, which may
compromise the privacy required for test completion.
High temperatures and delays in completing the test
are known to affect the sensitivity of the immunochem-
ical FOBT test [99]. This problem has been noted in
several European countries and is likely to arise in Aus-
tralia where many regions experience extremely hot
conditions. In remote areas where postal collections are
infrequent, many completed kits could remain in post
boxes for several days before being collected and deliv-
ered to the laboratory.
vii) Literacy requirement Literacy is essentially a pre-
requisite for participation and completion of screening
tests distributed by post. The initial contact with poten-
tial participants is through a written letter and the infor-
mation material and the screening kit is with limited
and limited graphical instructions. An investigation into
the impact of health literacy on participation in CRC
screening revealed that lower literacy was associated
with reduced confidence and perceived self-efficacy in
carrying out the test and lower likelihood of completion
[100]. Being able to read the instructions is imperative
to completing the test correctly; the task and instruc-
tions are complicated, relying on a wordy instruction
sheet. While the kit provides instructions in a number
of languages, Indigenous languages are not included.
Potential participants may feel unable or unsure about
whether they would be completing it correctly. Although
doing the test at home might appear be more appealing
and less shameful, correct execution remains a chal-
lenge. The requirement to fill identification details on
small labels to be stuck on the sample sticks presents
another potential obstacle. These literacy-related issues
are a major drawback of the postal distribution of test
kits where language and poor literacy is a critical, often
unaddressed, factor influencing cancer screening
behaviour.
The qualitative evaluation report of the NBCSP noted
that language and literacy issues were a major barrier
for Indigenous Australians with many unable to under-
s t a n do rr e a dt h ei n s t r u c t i o n sa n dp u t t i n gt h ek i ta s i d e
after opening it. Furthermore, it was noted that Indigen-
ous people were unlikely to seek assistance if they
experienced difficulties. An analysis of those who did
not complete the screening test revealed that they were
less confident about their ability to take the test and the
accuracy of the results. They also had lower levels of
English competency, felt overwhelmed with the contents
of the kit and confused regarding what had to be sent
back. Community health workers were an important
source of information and support for Indigenous peo-
ple compared to GPs and helped to encourage participa-
tion. In some cases Indigenous people did not respond
until they were contacted by a health worker and many
were more interested in undertaking the test once they
had spoken to a health worker about it [82]. With test
kits mailed to home, an individual’s decision about com-
pleting the test (or not) is made without discussion with
a health practitioner over the benefits and harms of par-
ticipation. Encouragement and assistance from health
personnel is important for facilitating participation.
It is well known that Indigenous people respond to
information more effectively through oral and pictorial,
rather than written methods of communication [101];
this should be taken into consideration in the future
design of the NBCSP. An educational bowel cancer
screening flipchart for Indigenous Australians has been
developed using pictures to demonstrate how to do the
test. Animated video is currently being used in the USA
to encourage screening uptake among American Indians
[102]. Similar methods could be used in Australia in
contexts where such technology is accessible.
viii) Nature of the screening test This issue is underex-
plored in regard to CRC screening. Although discomfort
and uneasiness with handling faecal material could be
experienced by almost all participants, little is known
about any taboos in Indigenous culture in regard to this.
The qualitative evaluation of the pilot did not find any
s i g n i f i c a n ti s s u e sw i t ht h i s ,a l t h o u g hi tw a sn o t e dt h a t
those selected to participate in interviews were those
who were comfortable to discuss the topic [82]. This
potentially significant barrier to participation needs
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Page 14 of 21Table 5 Interventions for improving uptake of CRC screening in disadvantaged and minority groups
Approach Study Type Screening
type
Population group
targeted
Observed changes in screening uptake
or intent to screen for CRC
1. Organizational/system changes
Patient navigators to overcome patient
reported barriers from screening to
treatment [123]
RCT Any CRC
screening
Low income and
non-English
speaking
Uptake of CRC screening post-intervention
was 27% vs 12% (p‹ 0.001) before
intervention.
Culturally sensitive patient navigators
and physician recommendation [124]
RCT Endoscopy
and FOBT
Low income,
Hispanic patients
attending primary
care practice
Completion of endoscopy 6 months post
intervention was 15.8% in intervention
group vs 5% in control (physician
recommendation only) (p= 0.019)
Completion of FOBT 3 months post
intervention was 42.1% in intervention
group vs 25% in control group (p = 0.086)
Patient navigator combined with
reminder letter [125]
Intervention Any CRC
screening English speaking,
Immigrants from
Brazil, Portugal &
Haiti
31% of intervention group vs 9% control
patients completed screening after 6
months
2. Targeting of healthcare users
Culturally appropriate intervention
using health educator and bilingual
educational material [126]
RCT FOBT Chinese Americans Uptake of FOBT after 6 months was 69.5%
intervention group vs 27% control group
Personalized and tailored interventions
[127,128]
Four groups;
1-Tailored intervention
2-Standard intervention
3-Tailored intervention plus phone
reminder
4-Control
RCT [128] Any CRC
screening
Mixture of African
American (58%)
and white
Screening assessed 2 years post
intervention:
Screening completion among those in the
intervention groups ranged from 44-48% vs
33% control group (p‹0.05) [128]
Storytelling to promote CRC screening
[110,129]
RCT Endoscopy Low SES Latino Intent to obtain CRC screening via
endoscopy increased in those exposed to
storytelling compared to those exposed to
risk tool based information (p = 0.038)
Community based awareness and
educational interventions [130]
Participatory using
intervention material
developed through
participatory approach
Any CRC
screening
Rural white
Intention to screen increased significantly in
those exposed to educational materials and
who had not been tested in the last 5 yrs
compared to those that had (p = 0.025).
Community-based participatory [131]
Using culturally relevant approach and
education held on a ‘family day’. Followed
by intensive follow-up and
encouragement of participants by letters
and phone calls
Participatory Any CRC
screening
Rural Native
Hawaiian in Hawaii
Increase in compliance with CRC screening
in both men and women.
CRC screening 6 months post intervention
increased in men from 39% to 75% (p =
0.002) and in women 36% to 76% (p =
0.002)
Limitations- small sample size (28 men and
25 women)
Culturally appropriate education to
enhance knowledge and screening
[132]
Assigned to one of three groups:
1. Cultural & self-empowerment group
2. Traditional group
3. Modified cultural group
4. Control
Experimental/repeated
measures
FOBT African-American
Elders Knowledge assessed at 6 and 12 months.
FOBT screening assessed at 12 months and
found greater participation in those in
Cultural & Self Empowerment group.
Intensive one-on-one patient
education [133]
RCT FOBT Ethnically diverse
group Proportion of patients returning FOBT was
significantly higher in intensive education
group compared with those receiving
standard education (65.6% vs 51.3% p‹0.01)
Christou et al. BMC Public Health 2010, 10:373
http://www.biomedcentral.com/1471-2458/10/373
Page 15 of 21further exploration so that alternative approaches could
be considered. For example, an individual could provide
as t o o ls a m p l et oac l i n i cw h e r ean u r s eo rh e a l t h
worker could be responsible for completing the test
with the kit. This would also ensure the test is com-
pleted correctly. Currently Australia only offers one
option for CRC screening - the FOBT. Exploring prefer-
ences for screening methodologies among different
groups and incorporating their preferences into practice
is a possibility for increasing adherence to CRC screen-
ing [103,104].
ix) Barriers to compliance with follow-up and treat-
ment Completion of the screening test is only one part
of the screening process. A positive test must be fol-
lowed up with appropriate diagnostic evaluation such as
a colonoscopy. This step in the screening pathway poses
a great challenge for Indigenous people, particularly
those living in rural areas, where colonoscopies are not
available locally requiring them to travel long distances.
Leaving the community and family is known to be a sig-
nificant barrier to compliance with cancer treatment in
Indigenous people [3,74]. Results from the 2009 NBCSP
monitoring report show that only 43% of total partici-
pants with a positive FOBT were followed up by GPs
[10] with inadequate follow-up following a positive
FOBT test an identified issue for CRC screening
[25,105].
Although the NBCSP monitoring reports indicate no
differences between the follow-up of Indigenous and
non-Indigenous people, it is likely to be worse among
Indigenous and minority populations particularly those
living remotely. This area needs to be addressed through
intensive follow-up and interventions to encourage con-
firmation of diagnosis and subsequent access to and
compliance with treatment.
2.3 Strategies used for improving participation in CRC
screening of Indigenous and ethnic minorities
internationally
In recent years there has been a proliferation of litera-
ture investigating CRC screening in minority and under-
served groups, identifying barriers to screening and
examining how program design can be improved to
reduce disparities in cancer outcomes. Intervention stu-
dies for improving CRC screening uptake and adherence
have been undertaken in the USA. However, the num-
ber of studies targeting Indigenous people is minimal
with the majority focusing on other ethnic minority and
low literacy groups including African American, Latino
and Chinese immigrants. However, these studies provide
some information on what may or may not work in
considering implementation in Australia.
The approaches taken have included education and
educational sessions, community based interventions,
the use of lay health workers, storytelling, mailed inter-
ventions, mail-out reminder systems, telephone inter-
views, and more recently the utilisation of patient
navigators and electronic/educational decision aids
[106-110]. The majority are tailored to the characteris-
tics of the target group, incorporating their own lan-
guages and motifs. A review by Vernon [111] found that
those incorporating intensive and personal follow-up
appeared to increase adherence more successfully [111].
A more recent systematic review of interventions identi-
fied organisational level changes as being most effective
Table 5: Interventions for improving uptake of CRC screening in disadvantaged and minority groups (Continued)
Telephone support intervention [134] RCT Any CRC
screening
Minority, low
income women
Proportion of women completing CRC
screening increased from 39% to 54% in
the intervention group and 39% to 50% in
the control group (p = 0.13)
Tailored telephone outreach [135] RCT Any CRC
screening
Minority
CRC screening compliance 6 months post
intervention was 27% in intervention group
vs 6.1% in control group (mailed print
material)
Education with Elderly Educators [136]
Four educational methods:
1. Elderly Educators
2. Elderly Educators plus Adaption for
Aging Changes method
3. Adaption for Aging Changes method
4. Traditional method
2-by-2 factorial design FOBT Socioeconomically
disadvantaged
African Americans
and White
Participation in FOBT was 93% in those
receiving combination of Elderly Educators
plus Adaption for Aging Changes method,
63% in those exposed to Elderly Educators
only and 43% participation in those
receiving Adaptation for Aging changes
method only and 56% exposed to
traditional method.
Video-based education [137] RCT FOBT Majority had less
than high school
education
69.6% of intervention group returned FOBT
vs 54.4% in control group (p = 0.035)
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Page 16 of 21at enhancing screening behaviour. Changes included
establishing separate clinics for screening and incorpor-
ating non-physicians into the screening process
[106,112]. Table 5 summarises these intervention stu-
dies. The range of interventions trialed highlights diffi-
culties in making comparisons because of differences in
outcome measures, target populations, and the type of
screening test used. As many of the interventions were
carried out in the USA, outcome measures were usually
uptake of any type of CRC screening. Interventions to
ensure that those with a positive FOBT follow through
with colonoscopy are lacking. Patient navigators could
play a critical role, helping individuals to overcome
many of these barriers in obtaining quality cancer care
[113]. Initial evaluation of a small Indigenous women’s
cancer support group established in regional Western
Table 6 Recommendations for alterations to Australia’s NBCSP to improve access and participation for Indigenous
Australians
Recommendations
1) Alternative means of distribution of FOBT test kits
Provide an alternative mechanism of delivery and return of kit (to target those who may not have a post box or Medicare enrolment). This could
entail supplying hospitals and AMSs with kits to distribute to increase opportunistic screening.
2) Dedicated health personnel for follow-up and support
Ensure there is a dedicated health worker knowledgeable about the program to follow-up individuals receiving a kit and to provide personalised
advice, education and assistance with completing the test. Intensive support of Aboriginal people will be necessary for increasing screening uptake.
3) Integration of screening into primary care/general chronic disease management
GPs have an important role in actively encouraging participation in screening [96], however many GPs are neither supportive of or knowledgeable
enough about the program nor do they have time to discuss screening with patients [138,139]. Their key role in the program means that whether a
patient has a regular GP or not can affect participation and attendance to follow up procedures. (If an individual receives a positive test but has not
nominated a GP, then is it is up to the individual to follow up their test result)
The key role of the GP in activating post screening diagnostic and follow up requires reconsideration of alternative approaches using either
dedicated health professionals or centralised screening centres to support a greater number of people having access to the screening kit and
opportunities for referral. Opportunistic screening through file tagging is also another potential way in which to improve participation [140].
Completion of forms by GPs and colonoscopists should be mandatory as should identification of Indigenous status in order to attain greater quality
data that will give an indication of the burden of bowel cancer and how the program impacts on incidence and mortality, and levels of follow-up
and treatment. This is also important for the general population. Perhaps greater incentives for health professionals may be needed for this as
presently GPs receive $7.70 for each form submitted [95].
The administrative role of GPs in the program is poorly defined and needs attention with accountability and responsibilities clarified, and appropriate
interventions implemented to increase GP’s awareness of their roles and responsibilities [95].
4) Improve health promotion and availability of culturally relevant educational materials
Greater coverage of bowel cancer screening in health promotion campaigns and the media is needed to increase general knowledge and
awareness in the population. This will also help to remove the shame and stigma associated with discussing bowel cancer. Promotional activities
should occur prior to individuals receiving the kit so that there is some awareness and expectation of the test.
Increase the availability of culturally appropriate, Indigenous-specific educational resources, if possible in local languages and including local terms
for main parts of the body. Translated materials were available in 13 languages for CALD groups during the pilot therefore it should be possible to
make information and brochures available in Indigenous languages.
To overcome the literacy barrier, greater emphasis on pictorial methods of education including videos and diagrams should be included with the
screening kit.
5) More community-based participatory research into Indigenous understandings and perceptions of bowel cancer
Further research into Aboriginal understandings and perceptions of CRC and CRC screening, including knowledge, beliefs and attitudes is necessary
to inform appropriate approaches for intervention and resources. This includes a greater emphasis on participatory methods of health promotion.
6) Implement ongoing annual or biennial screening for CRC
Currently the NBCSP is offering only once of testing to the Australian population and only to those in the specified age brackets. Provision of
funding for ongoing rounds of screening are necessary for not only targeting a greater number of people and enhancing opportunities for
screening uptake, but allowing time for familiarization with the program[141].
7) Ensure Indigenous Australians have access to FOBT kits from the age of 45 years
Given the younger age at which CRC is occurring among Indigenous people, consideration should be given to ensuring screening kits are available
to Indigenous Australians from the age of 40-45 years.
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families of those with cancer and help patients through
their cancer journey could potentially be an effective
model for facilitating Indigenous participation in bowel
cancer screening while also providing assistance with
follow-up tests and treatment [114]. Such community-
based and community-led groups could make a signifi-
cant contribution and further evaluation of their influ-
ence on cancer screening behaviours would provide the
evidence needed for this.
Discussion and Conclusion
Bowel cancer screening can provide important benefits
and reduce mortality from bowel cancer. However, orga-
nised nationwide screening programs such as that intro-
duced in Australian may overlook the needs and beliefs
of minority groups, including Indigenous Australians,
g i v e nt h e i rf o c u so nw h a ti sm o s tc o s te f f e c t i v ef o rt h e
country as a whole. Strategies and interventions at sev-
eral levels are needed to improve CRC screening uptake
and reduce access inequities. These range from policy
and program changes to remove many of the structural
barriers, to targeting individual, behavioural and attitudi-
nal variables and enhancing provider knowledge and
incentives.
There is a need to understand the reasons behind the
low participation of Indigenous and CALD groups in
greater depth. Research and consultation with Indigen-
ous populations is needed to elucidate the barriers most
impacting on participation and to better understand
what will work for Indigenous people and other minor-
ity groups in Australia - to date, largely unexplored.
Results from pilot studies in Queensland and Victoria
investigating alternative mechanisms for delivering the
screening kits to Indigenous populations will be infor-
mative when available, and should shed some light on
effective strategies to improve participation. However, as
it is unlikely that the screening test of choice will be
changed in the near future, several modifications to the
current program can be made in the shorter term to
enhance access to the program for Indigenous Austra-
lians and are detailed in Table 6.
The nature of the NBCSP may exacerbate the wide
disparities in cancer outcomes that exist between Indi-
genous and non-Indigenous Australians; the programme
design favours participation by the majority and unin-
tentionally excludes disadvantaged and remote popula-
tions, perpetuating prevailing health inequities. This
review provides evidence that the program needs to be
modified to facilitate access to and participation by Indi-
genous people and other minority populations through
a more community-based, people-friendly approach, bet-
ter integrated into primary health care. Modifications
such as those we have described are needed, taking into
account epidemiological differences, life circumstances,
and specific participation barriers experienced by Indi-
genous people.
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